Shield Therapeutics drops as CFO exits and Medicaid concerns weigh
Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) fell 12% to 7.71p after the group reported…
proactiveinvestors.co.uk
BBWI(BBWI)
BBWI
Next earnings: Jun 4, 2026 · Before open
Signal
Bullish Setup2↑
PRICE
Prev Close
18.33
Open
18.54
Day Range18.51 – 19.75
18.51
19.75
52W Range14.28 – 34.66
14.28
34.66
25% of range
VOLUME & SIZE
Avg Volume
5.8M
FUNDAMENTALS
P/E Ratio
6.3x
Value territory
EPS (TTM)
—
Div Yield
0.02%
Beta
1.39
Market-like
Performance
1D↑
+6.06%5D
-4.52%1M
+4.12%3M
-10.83%6M
-18.76%YTD
-3.19%1Y↓
-36.28%Best: 1D (+6.06%)Worst: 1Y (-36.28%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
44% gross marginValuation
CHEAP
P/E 6x vs ~20x sectorHealth
MODERATE
CR 1.3 · FCF $4.09/shBullish
Key MetricsTTM
Market Cap$3.91B
Revenue TTM$7.29B
Net Income TTM$649.00M
Free Cash Flow$865.00M
Gross Margin43.7%
Net Margin8.9%
Operating Margin15.4%
Return on Equity-44.2%
Return on Assets12.8%
Debt / Equity-3.87
Current Ratio1.27
EPS TTM$3.07
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong2 watch1 concern
53/100Liquidity
1.27Watch
Leverage
-3.87Strong
Coverage
4.1xWatch
ROE
-44.2%Concern
ROIC
21.0%Strong
Cash
$953MStrong
ANALYST COVERAGE20 analysts
HOLD
▲ +5.5%upside to target
L $17.00
Med $20.50consensus
H $26.00Stock Health
Composite Score
3 of 5 signals bullish
8/10
Technicals
●
✓RSI RangeRSI 50 — Bullish momentum
Volume
●
✓Volume FlowLean Accumulation
Fundamentals
●
✓Last EarningsBeat estimates
●
~Analyst ConsensusHold
●
~LiquidityCurrent Ratio 1.27
Upcoming Events
EEarnings ReportMay 2, 2026
Tomorrow
DEx-Dividend DateJul 30, 2026
In 90 days
PDividend PaymentOct 27, 2026
In 179 days
FinancialsFull statements →
Technicals
Technical SetupMIXED
Technicals →Trend
▼ DowntrendDeath Cross · 50D trails 200D by 14.9%
-2.7% vs SMA 50 · -17.2% vs SMA 200
Momentum
RSI50.4Neutral territory
MACD+0.05Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$34.66+78.3%
EMA 200
$23.54+21.1%
EMA 50
$19.81+1.9%
Current
$19.44
52W Low
$14.28-26.5%
52-Week RangeMid-range
$14.2825th %ile$34.66
Squeeze SetupVolume-based
Moderate Squeeze SetupAccumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
20-Day Money Flow
Acc days:5
Dist days:3
Edge:+2 acc
Volume Context
Avg Vol (50D)5.4M
Recent Vol (5D)
4.1M-24%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 14 analysts
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $7.4B $7.3B–$7.5B | — | $3.89 | — | ±2% | High8 |
FY2025 | $7.3B $7.3B–$7.3B | ▼ -1.6% | $3.26 | ▼ -16.3% | ±2% | High14 |
FY2026(current) | $7.2B $7.1B–$7.3B | ▼ -1.4% | $2.98 | ▼ -8.6% | ±3% | High11 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryBBWI
Last 8Q
+6.3%avg beat
Beat 6 of 8 quartersMissed 1↓ Estimates falling+15%
Q2'24
+4%
Q3'24
+4%
Q4'24
+2%
Q1'25
+17%
Q2'25
—
Q3'25
-8%
Q4'25
+16%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →Neutral — mixed activity
90d▲ 0▼ 1
CitigroupBuy → Neutral
Feb 17
DOWNGRADE
Telsey AdvisoryOutperform → Market Perform
Nov 21
DOWNGRADE
Goldman SachsBuy → Neutral
Nov 20
DOWNGRADE
CitigroupNeutral → Buy
Feb 28
UPGRADE
Wells FargoOverweight
Feb 27
UPGRADE
BarclaysEqual-Weight
Feb 27
UPGRADE
Wells FargoEqual-Weight → Overweight
Jan 10
UPGRADE
BarclaysEqual-Weight → Overweight
Aug 1
UPGRADE
Wells FargoOverweight → Equal-Weight
Jan 6
DOWNGRADE
Cowen & Co.Market Perform
May 2
UPGRADE
Insider Activity
SEC Filings →6 Buys/0 SellsNet Buying
Symancyk James KevinDir
$351K
Nov 24
BUY
Nash Sarah EDir
$156K
Nov 24
BUY
Voskuil Steven EDir
$301K
Nov 21
BUY
Steinour Stephen DDir
$100K
Nov 21
BUY
Hondal FrancisDir
$50K
Nov 21
BUY
Brady LucyDir
$50K
Nov 21
BUY
Financials
Dividends4.12% yield
3 yrs of paymentsAnnual Yield4.12%
Quarterly Div.$0.2000
Est. Annual / Share$0.80
FrequencyQuarterly
Q2'24
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.
2.9M▲2
Retirement Systems of Alabama
836K▲3
ARGA Investment Management, LP
546K▼4
OLD NATIONAL BANCORP /IN/
499K▲5
STRS OHIO
452K▼6
HSBC HOLDINGS PLC
297K▼7
Nuveen, LLC
288K▼8
KWMG, LLC
214K▲News & Activity
BBWI News
20 articles · 4h ago
Lotus Resources Limited (LTSRF) Q3 2026 Earnings Call Transcript
seekingalpha.com
H2O America: Dividend King Selling At A Discount To Fair Market Value
seekingalpha.com
FAST-GROWING KIA AMERICA EXTENDS RECORD ANNUAL SALES PACE THROUGH APRIL
prnewswire.com
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
prnewswire.com
SP Group A/S (SPGGF) Q1 2026 Earnings Call Transcript
seekingalpha.com
61% of North America Middle Market Companies Use Cards to Speed Cash Flow
pymnts.com
WEX Puts Fraud Detection on a 500-Millisecond Clock
pymnts.com
Mastercard Sees Data Moving Payments From KYC to KYA
pymnts.com
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
Roku: Undeniable Cash Flow Growth As Roku Platform Scales
seekingalpha.com
Schwab Marks Second Annual National Investing Day with Industry and Community Partners
businesswire.com
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
globenewswire.com
AstraZeneca's Breast-Cancer Candidate Drug Loses FDA Panel Vote
wsj.com
Twilio Inc. (TWLO) Q1 2026 Earnings Call Transcript
seekingalpha.com
Reddit, Inc. (RDDT) Q1 2026 Earnings Call Transcript
seekingalpha.com
Everyone's Talking About NVIDIA's Moving Averages. Smart Money Is Watching CrowdStrike Instead
247wallst.com
Under Armour: Waiting On The Turnaround While Downside Looks Limited
seekingalpha.com
Form 8.3 - [ANIMALCARE GROUP PLC - 30 04 2026] - (CGWL)
globenewswire.com
About
on august 2, 2021, l brands (nyse: lb) completed the separation of the victoria’s secret business into an independent, public company through a tax-free spin-off to l brands shareholders. the new company, named victoria’s secret & co., includes victoria’s secret lingerie, pink and victoria’s secret beauty. victoria’s secret & co. is a nyse listed company trading under the ticker symbol vsco.in conjunction with this announcement, l brands changed its name to bath & body works, inc. and now trades under the ticker symbol bbwi.for more information on bath & body works, inc. or victoria’s secret & co., please visit the corporate websites.
Jeff KingVice President of ESG
Brian K. LeinbachExecutive Vice President & Chief Information Officer
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
BBWI◀ | $19.44 | +6.06% | $3.9B | 6.3 | -21.9% | 890.1% | 1500 |
| $396.06 | +0.57% | $2.1T | 28.7 | +3296.8% | 4510.0% | 1500 | |
| $91.86 | +2.89% | $318.3B | 14.0 | +318.8% | 1510.7% | 1500 | |
| $131.91 | +1.13% | $306.2B | 22.6 | +586.3% | 1305.9% | 1500 | |
| $187.37 | +1.17% | $290.5B | 28.1 | +862.9% | 1745.9% | 1500 | |
| $147.85 | +3.44% | $282.1B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $90.67 | +1.98% | $256.7B | 14.5 | -591.0% | 668.4% | 1500 | |
| Sector avg | — | +2.46% | — | 19.3 | +721.3% | 1885.0% | 1500 |